Novel vascular endothelial growth factor expression inhibitors

(19)

(11)

EP 2 561 882 A3

(12)	EUROPEAN PATENT APPLICATION

(88)	Date of publication A3:
	17.04.2013 Bulletin 2013/16

(43)	Date of publication A2:
	27.02.2013 Bulletin 2013/09

(21)	Application number: 12169135.6

(22)	Date of filing: 15.09.2006

(27)	Previously filed application: 15.09.2006 PCT/JP2006/318793

(51)

International Patent Classification (IPC):

A61K 36/18^(2006.01)
A61P 9/10^(2006.01)
A61P 17/02^(2006.01)
A61P 19/02^(2006.01)
A61P 27/06^(2006.01)
A61P 35/00^(2006.01)

A61K 8/97^(2006.01)
A61P 11/00^(2006.01)
A61P 17/06^(2006.01)
A61P 27/02^(2006.01)
A61P 29/00^(2006.01)
A61K 36/8994^(2006.01)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30)

Priority:

16.09.2005 JP 2005270179
26.09.2005 JP 2005277870
16.09.2005 JP 2005269646

(62)	Application number of the earlier application in accordance with Art. 76 EPC:
	06798232.2 / 1938827

(71)	Applicant: SHISEIDO COMPANY, LTD.
	Tokyo 104-8010 (JP)

(72)	Inventors:
	Hasegawa, Kiyotaka Kanagawa 2248558 (JP) Inomata, Shinji Kanagawa 2248558 (JP) Umishio, Kenichi Kanagawa 2248558 (JP)

(74)	Representative: Galup, Cédric Olivier Nicolas
	Santarelli 146 Rue Paradis 13294 Marseille Cedex 6 13294 Marseille Cedex 6 (FR)

(54)	Novel vascular endothelial growth factor expression inhibitors

(57) The invention provides anti-aging agents, angiogenesis inhibitors and vascular endothelial growth factor (VEGF) expression inhibitors containing coix extract.

Search report

Search report